Carl Zeiss Meditec logo
AFX logo

Carl Zeiss MeditecWBAG:AFX Stock Report

Market Cap €5.0b
Share Price
n/a
1Y-42.2%
7D12.1%
Portfolio Value
​
View

Carl Zeiss Meditec AG

WBAG:AFX Stock Report

Market Cap: €5.0b

AFX Stock Overview

Operates as a medical technology company in Germany, rest of Europe, North America, and Asia. More details

AFX fundamental analysis
Snowflake Score
Valuation4/6
Future Growth3/6
Past Performance2/6
Financial Health5/6
Dividends0/6

Rewards

Trading at 20.2% below our estimate of its fair value

Earnings are forecast to grow 15.19% per year

Risk Analysis

Highly volatile share price over the past 3 months compared to the Austrian market

Profit margins (8.7%) are lower than last year (13.9%)


My Notes

Capture your thoughts, links and company narrative

Carl Zeiss Meditec AG Competitors

Getinge

OM:GETI B

SEK 60.1b

Ambu

CPSE:AMBU B

DKK 37.1b

Jiangsu Yuyue Medical Equipment & Supply

SZSE:002223

CN¥35.9b

Integer Holdings

NYSE:ITGR

US$4.8b

Price History & Performance

Summary of share price highs, lows and changes for Carl Zeiss Meditec
Historical stock prices
Current Share Price€58.75
52 Week High€123.15
52 Week Low€44.40
Beta1.06
1 Month Change28.33%
3 Month Change2.26%
1 Year Change-42.18%
3 Year Change-57.54%
5 Year Change-49.57%
Change since IPO38.24%

Recent News & Updates

Recent updates

Shareholder Returns

AFXAT Medical EquipmentAT Market
7D12.1%3.1%0.8%
1Y-42.2%16.7%5.3%

Return vs Industry: AFX underperformed the Austrian Medical Equipment industry which returned 16.6% over the past year.

Return vs Market: AFX underperformed the Austrian Market which returned 4.3% over the past year.

Price Volatility

Is AFX's price volatile compared to industry and market?
AFX volatility
AFX Average Weekly Movement6.9%
Medical Equipment Industry Average Movement6.4%
Market Average Movement4.0%
10% most volatile stocks in AT Market6.1%
10% least volatile stocks in AT Market2.1%

Stable Share Price: AFX's share price has been volatile over the past 3 months compared to the Austrian market.

Volatility Over Time: AFX's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of Austrian stocks.

About the Company

FoundedEmployeesCEOWebsite
18465,730Markus Weberwww.zeiss.com/meditec-ag/de/investor-relations.html?vaURL=www.zeiss.de/meditec-ag/ir

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.

Carl Zeiss Meditec AG Fundamentals Summary

How do Carl Zeiss Meditec's earnings and revenue compare to its market cap?
AFX fundamental statistics
Market cap€5.01b
Earnings (TTM)€178.73m
Revenue (TTM)€2.07b

28.8x

P/E Ratio

2.5x

P/S Ratio

Is AFX overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
AFX income statement (TTM)
Revenue€2.07b
Cost of Revenue€977.50m
Gross Profit€1.09b
Other Expenses€909.90m
Earnings€178.73m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Feb 12, 2025

Earnings per share (EPS)2.04
Gross Margin52.69%
Net Profit Margin8.65%
Debt/Equity Ratio19.6%

How did AFX perform over the long term?

See historical performance and comparison

Dividends

1.0%

Current Dividend Yield

30%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/30 09:21
End of Day Share Price 2025/01/30 00:00
Earnings2024/09/30
Annual Earnings2024/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Carl Zeiss Meditec AG is covered by 31 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Samuel EnglandBerenberg
Scott BardoBerenberg
Julien OuaddourBofA Global Research